1. Home
  2. ARTL vs ICON Comparison

ARTL vs ICON Comparison

Compare ARTL & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • ICON
  • Stock Information
  • Founded
  • ARTL 2011
  • ICON 2023
  • Country
  • ARTL United States
  • ICON Greece
  • Employees
  • ARTL N/A
  • ICON N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • ICON
  • Sector
  • ARTL Health Care
  • ICON
  • Exchange
  • ARTL Nasdaq
  • ICON Nasdaq
  • Market Cap
  • ARTL 3.7M
  • ICON 3.4M
  • IPO Year
  • ARTL N/A
  • ICON 2024
  • Fundamental
  • Price
  • ARTL $1.21
  • ICON $2.09
  • Analyst Decision
  • ARTL Strong Buy
  • ICON Strong Buy
  • Analyst Count
  • ARTL 2
  • ICON 1
  • Target Price
  • ARTL $5.50
  • ICON $7.00
  • AVG Volume (30 Days)
  • ARTL 28.9K
  • ICON 16.9K
  • Earning Date
  • ARTL 11-12-2024
  • ICON 02-15-2025
  • Dividend Yield
  • ARTL N/A
  • ICON 7.89%
  • EPS Growth
  • ARTL N/A
  • ICON N/A
  • EPS
  • ARTL N/A
  • ICON 0.35
  • Revenue
  • ARTL N/A
  • ICON $4,810,000.00
  • Revenue This Year
  • ARTL N/A
  • ICON $41.29
  • Revenue Next Year
  • ARTL N/A
  • ICON $130.65
  • P/E Ratio
  • ARTL N/A
  • ICON $6.03
  • Revenue Growth
  • ARTL N/A
  • ICON 5.71
  • 52 Week Low
  • ARTL $0.91
  • ICON $1.81
  • 52 Week High
  • ARTL $1.75
  • ICON $3.85
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 64.07
  • ICON N/A
  • Support Level
  • ARTL $1.09
  • ICON N/A
  • Resistance Level
  • ARTL $1.19
  • ICON N/A
  • Average True Range (ATR)
  • ARTL 0.06
  • ICON 0.00
  • MACD
  • ARTL 0.01
  • ICON 0.00
  • Stochastic Oscillator
  • ARTL 100.00
  • ICON 0.00

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: